APA (7th ed.) Citation

R, A., SD, A., G, F., B, P., P, R., LM, R., . . . GL, B. (2022). Effects of canagliflozin versus finerenone on cardiorenal outcomes: Exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 37(7), 1261. https://doi.org/10.1093/ndt/gfab336

Chicago Style (17th ed.) Citation

R, Agarwal, et al. "Effects of Canagliflozin Versus Finerenone on Cardiorenal Outcomes: Exploratory Post Hoc Analyses from FIDELIO-DKD Compared to Reported CREDENCE Results." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association 37, no. 7 (2022): 1261. https://doi.org/10.1093/ndt/gfab336.

MLA (9th ed.) Citation

R, Agarwal, et al. "Effects of Canagliflozin Versus Finerenone on Cardiorenal Outcomes: Exploratory Post Hoc Analyses from FIDELIO-DKD Compared to Reported CREDENCE Results." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, vol. 37, no. 7, 2022, p. 1261, https://doi.org/10.1093/ndt/gfab336.